Pharmaceutical Quality Assurance (SHORT ESSAYS)
Q3. Explain the various steps involved in the purchase of equipment.
📘 Reference:
Nirali Prakashan, Pharmaceutical Quality Assurance, Ch. 5, pp. 68–71
Thakur Publication, Pharmaceutical Quality Assurance, Unit II, pp. 75–79
Introduction
The purchase of pharmaceutical equipment is a critical activity ensuring that all
machinery and instruments used in manufacturing, testing, and packaging meet
the required quality, safety, and regulatory standards.
Properly designed and validated equipment ensures consistent product quality,
compliance with GMP, and reduced downtime.
Steps Involved in Equipment Purchase
1. Identification of Need
The first step is to determine the need for equipment based on production or
analytical requirements.
The User Department (Production/QC) raises a User Requirement
Specification (URS) document stating purpose, capacity, and operational
conditions.
2. Vendor Selection
Vendors are evaluated for technical capability, GMP compliance, past
performance, and after-sales service.
Approved vendors are listed in the Approved Vendor List (AVL).
3. Request for Quotation (RFQ)
The Purchase Department sends RFQ to shortlisted suppliers, asking for
technical details, price, and delivery schedule.
4. Technical Evaluation
Cross-functional teams (Engineering, Production, QA) compare the technical
specifications with URS.
GMP and safety standards are verified.
5. Purchase Order (PO)
The Purchase Department issues a formal PO specifying the equipment model,
price, terms, and conditions.
6. Equipment Delivery and Inspection
Upon delivery, incoming inspection ensures all parts, accessories, and
documentation are complete.
Equipment is labeled as “Under Installation” until qualified.
7. Installation and Qualification
Installation Qualification (IQ), Operational Qualification (OQ), and
Performance Qualification (PQ) are carried out.
Certificates of calibration and validation reports are reviewed by QA.
8. Documentation and Approval
All equipment documents — manuals, validation reports, and calibration logs —
are filed in the Equipment History File (EHF).
QA gives final approval for use.
Diagram
(Equipment Purchase Flow Diagram — from Nirali Prakashan p.70)
Need → Vendor Selection → Quotation → Evaluation → Purchase Order → Delivery →
Installation → Qualification → Approval
Summary / Memory Trick
,“Never Verify Quotes Properly During Installation”
👉 N – Need
👉 V – Vendor Selection
👉 Q – Quotation
👉 P – Purchase Order
👉 D – Delivery & Installation
Frequently Asked in RGUHS: ✅
“Explain steps in purchase of equipment” — Repeated in 2019, 2021, 2023
Q3(a) Define Cross-Contamination. How it is Prevented in Production
Facilities
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 4, pp. 61–64
Pharmaceutical Quality Assurance – Thakur Publication, Unit II, pp. 82–85
WHO GMP, TRS 986, Annex 2
Schedule M (Drugs & Cosmetics Rules, India)
Definition
Cross-contamination is the unintentional transfer of one substance, product,
or microorganism to another during manufacturing, storage, or handling,
resulting in product impurity or safety compromise.
As per WHO (GMP):
“Cross-contamination is contamination of a material or product with another material
or product.”
It poses risks of adverse reactions, loss of product efficacy, and regulatory non-
compliance.
Sources of Cross-Contamination
1. Airborne particles from other products or powders.
2. Shared equipment without adequate cleaning.
3. Improper material movement or personnel flow.
4. Dust, aerosols, or vapors from active ingredients.
5. Inadequate waste disposal or ventilation.
6. Contaminated clothing or gloves of personnel.
Prevention of Cross-Contamination in Production Facilities
1. Facility Design & Layout
Dedicated manufacturing areas for potent drugs (e.g., hormones, antibiotics).
Unidirectional flow of men and materials.
Airlocks, pass boxes, and differential air pressure (DAP) systems.
Smooth, washable walls and floors.
2. Air Handling System (HVAC)
HEPA filtration to remove particles and microorganisms.
Separate AHUs for different product areas.
Maintain 10–15 Pa pressure differentials to avoid mix-up of air streams.
3. Equipment Control
Dedicated or validated equipment for each product.
Cleaning validation after every batch changeover.
Use of closed systems and dust extraction units.
4. Personnel Control
Proper gowning procedures.
Training programs on hygiene and GMP.
, Entry restricted by access control systems.
5. Documentation & SOPs
Written Standard Operating Procedures for cleaning, changeover, and
equipment use.
QA verification and record maintenance.
Diagram
(From Nirali Prakashan p. 63)
Cross-Contamination Prevention Flow:
Facility Design → HVAC Control → Equipment Cleaning → Personnel Hygiene → SOP
Compliance
Summary / Memory Trick
💡 “Five Fences Stop Contamination”
F – Facility Design
F – Filtration (HVAC)
S – Sanitation (Equipment)
C – Clothing (Personnel)
S – SOP Compliance
Frequently Asked in RGUHS: ✅
“Define cross-contamination and explain its prevention” — Repeated in 2018, 2020,
2022, 2024
Q3(a) Define Cross-Contamination. How it is Prevented in Production
Facilities
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 4, pp. 61–64
Pharmaceutical Quality Assurance – Thakur Publication, Unit II, pp. 82–85
WHO GMP, TRS 986, Annex 2
Schedule M (Drugs & Cosmetics Rules, India)
Definition
Cross-contamination is the unintentional transfer of one substance, product,
or microorganism to another during manufacturing, storage, or handling,
resulting in product impurity or safety compromise.
As per WHO (GMP):
“Cross-contamination is contamination of a material or product with another material
or product.”
It poses risks of adverse reactions, loss of product efficacy, and regulatory non-
compliance.
Sources of Cross-Contamination
1. Airborne particles from other products or powders.
2. Shared equipment without adequate cleaning.
3. Improper material movement or personnel flow.
4. Dust, aerosols, or vapors from active ingredients.
5. Inadequate waste disposal or ventilation.
6. Contaminated clothing or gloves of personnel.
Prevention of Cross-Contamination in Production Facilities
1. Facility Design & Layout
Dedicated manufacturing areas for potent drugs (e.g., hormones, antibiotics).
Unidirectional flow of men and materials.
, Airlocks, pass boxes, and differential air pressure (DAP) systems.
Smooth, washable walls and floors.
2. Air Handling System (HVAC)
HEPA filtration to remove particles and microorganisms.
Separate AHUs for different product areas.
Maintain 10–15 Pa pressure differentials to avoid mix-up of air streams.
3. Equipment Control
Dedicated or validated equipment for each product.
Cleaning validation after every batch changeover.
Use of closed systems and dust extraction units.
4. Personnel Control
Proper gowning procedures.
Training programs on hygiene and GMP.
Entry restricted by access control systems.
5. Documentation & SOPs
Written Standard Operating Procedures for cleaning, changeover, and
equipment use.
QA verification and record maintenance.
Diagram
(From Nirali Prakashan p. 63)
Cross-Contamination Prevention Flow:
Facility Design → HVAC Control → Equipment Cleaning → Personnel Hygiene → SOP
Compliance
Summary / Memory Trick
💡 “Five Fences Stop Contamination”
F – Facility Design
F – Filtration (HVAC)
S – Sanitation (Equipment)
C – Clothing (Personnel)
S – SOP Compliance
Frequently Asked in RGUHS: ✅
“Define cross-contamination and explain its prevention” — Repeated in 2018, 2020,
2022, 2024
Q4(a). Write a note on ISO 9000 with merits and demerits
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 10, pp. 170–174
Pharmaceutical Quality Assurance – Thakur Publication, Unit V, pp. 189–193
ISO 9000:2015 Standard, International Organization for Standardization
(Geneva)
WHO TRS 986, Annex 2
Introduction
ISO 9000 is a family of international standards developed by the International
Organization for Standardization (ISO) that provides guidelines for quality
management systems (QMS).
The ISO 9000 series helps pharmaceutical industries ensure that their products and
services consistently meet customer and regulatory requirements, and that
continuous improvement is maintained.
Q3. Explain the various steps involved in the purchase of equipment.
📘 Reference:
Nirali Prakashan, Pharmaceutical Quality Assurance, Ch. 5, pp. 68–71
Thakur Publication, Pharmaceutical Quality Assurance, Unit II, pp. 75–79
Introduction
The purchase of pharmaceutical equipment is a critical activity ensuring that all
machinery and instruments used in manufacturing, testing, and packaging meet
the required quality, safety, and regulatory standards.
Properly designed and validated equipment ensures consistent product quality,
compliance with GMP, and reduced downtime.
Steps Involved in Equipment Purchase
1. Identification of Need
The first step is to determine the need for equipment based on production or
analytical requirements.
The User Department (Production/QC) raises a User Requirement
Specification (URS) document stating purpose, capacity, and operational
conditions.
2. Vendor Selection
Vendors are evaluated for technical capability, GMP compliance, past
performance, and after-sales service.
Approved vendors are listed in the Approved Vendor List (AVL).
3. Request for Quotation (RFQ)
The Purchase Department sends RFQ to shortlisted suppliers, asking for
technical details, price, and delivery schedule.
4. Technical Evaluation
Cross-functional teams (Engineering, Production, QA) compare the technical
specifications with URS.
GMP and safety standards are verified.
5. Purchase Order (PO)
The Purchase Department issues a formal PO specifying the equipment model,
price, terms, and conditions.
6. Equipment Delivery and Inspection
Upon delivery, incoming inspection ensures all parts, accessories, and
documentation are complete.
Equipment is labeled as “Under Installation” until qualified.
7. Installation and Qualification
Installation Qualification (IQ), Operational Qualification (OQ), and
Performance Qualification (PQ) are carried out.
Certificates of calibration and validation reports are reviewed by QA.
8. Documentation and Approval
All equipment documents — manuals, validation reports, and calibration logs —
are filed in the Equipment History File (EHF).
QA gives final approval for use.
Diagram
(Equipment Purchase Flow Diagram — from Nirali Prakashan p.70)
Need → Vendor Selection → Quotation → Evaluation → Purchase Order → Delivery →
Installation → Qualification → Approval
Summary / Memory Trick
,“Never Verify Quotes Properly During Installation”
👉 N – Need
👉 V – Vendor Selection
👉 Q – Quotation
👉 P – Purchase Order
👉 D – Delivery & Installation
Frequently Asked in RGUHS: ✅
“Explain steps in purchase of equipment” — Repeated in 2019, 2021, 2023
Q3(a) Define Cross-Contamination. How it is Prevented in Production
Facilities
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 4, pp. 61–64
Pharmaceutical Quality Assurance – Thakur Publication, Unit II, pp. 82–85
WHO GMP, TRS 986, Annex 2
Schedule M (Drugs & Cosmetics Rules, India)
Definition
Cross-contamination is the unintentional transfer of one substance, product,
or microorganism to another during manufacturing, storage, or handling,
resulting in product impurity or safety compromise.
As per WHO (GMP):
“Cross-contamination is contamination of a material or product with another material
or product.”
It poses risks of adverse reactions, loss of product efficacy, and regulatory non-
compliance.
Sources of Cross-Contamination
1. Airborne particles from other products or powders.
2. Shared equipment without adequate cleaning.
3. Improper material movement or personnel flow.
4. Dust, aerosols, or vapors from active ingredients.
5. Inadequate waste disposal or ventilation.
6. Contaminated clothing or gloves of personnel.
Prevention of Cross-Contamination in Production Facilities
1. Facility Design & Layout
Dedicated manufacturing areas for potent drugs (e.g., hormones, antibiotics).
Unidirectional flow of men and materials.
Airlocks, pass boxes, and differential air pressure (DAP) systems.
Smooth, washable walls and floors.
2. Air Handling System (HVAC)
HEPA filtration to remove particles and microorganisms.
Separate AHUs for different product areas.
Maintain 10–15 Pa pressure differentials to avoid mix-up of air streams.
3. Equipment Control
Dedicated or validated equipment for each product.
Cleaning validation after every batch changeover.
Use of closed systems and dust extraction units.
4. Personnel Control
Proper gowning procedures.
Training programs on hygiene and GMP.
, Entry restricted by access control systems.
5. Documentation & SOPs
Written Standard Operating Procedures for cleaning, changeover, and
equipment use.
QA verification and record maintenance.
Diagram
(From Nirali Prakashan p. 63)
Cross-Contamination Prevention Flow:
Facility Design → HVAC Control → Equipment Cleaning → Personnel Hygiene → SOP
Compliance
Summary / Memory Trick
💡 “Five Fences Stop Contamination”
F – Facility Design
F – Filtration (HVAC)
S – Sanitation (Equipment)
C – Clothing (Personnel)
S – SOP Compliance
Frequently Asked in RGUHS: ✅
“Define cross-contamination and explain its prevention” — Repeated in 2018, 2020,
2022, 2024
Q3(a) Define Cross-Contamination. How it is Prevented in Production
Facilities
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 4, pp. 61–64
Pharmaceutical Quality Assurance – Thakur Publication, Unit II, pp. 82–85
WHO GMP, TRS 986, Annex 2
Schedule M (Drugs & Cosmetics Rules, India)
Definition
Cross-contamination is the unintentional transfer of one substance, product,
or microorganism to another during manufacturing, storage, or handling,
resulting in product impurity or safety compromise.
As per WHO (GMP):
“Cross-contamination is contamination of a material or product with another material
or product.”
It poses risks of adverse reactions, loss of product efficacy, and regulatory non-
compliance.
Sources of Cross-Contamination
1. Airborne particles from other products or powders.
2. Shared equipment without adequate cleaning.
3. Improper material movement or personnel flow.
4. Dust, aerosols, or vapors from active ingredients.
5. Inadequate waste disposal or ventilation.
6. Contaminated clothing or gloves of personnel.
Prevention of Cross-Contamination in Production Facilities
1. Facility Design & Layout
Dedicated manufacturing areas for potent drugs (e.g., hormones, antibiotics).
Unidirectional flow of men and materials.
, Airlocks, pass boxes, and differential air pressure (DAP) systems.
Smooth, washable walls and floors.
2. Air Handling System (HVAC)
HEPA filtration to remove particles and microorganisms.
Separate AHUs for different product areas.
Maintain 10–15 Pa pressure differentials to avoid mix-up of air streams.
3. Equipment Control
Dedicated or validated equipment for each product.
Cleaning validation after every batch changeover.
Use of closed systems and dust extraction units.
4. Personnel Control
Proper gowning procedures.
Training programs on hygiene and GMP.
Entry restricted by access control systems.
5. Documentation & SOPs
Written Standard Operating Procedures for cleaning, changeover, and
equipment use.
QA verification and record maintenance.
Diagram
(From Nirali Prakashan p. 63)
Cross-Contamination Prevention Flow:
Facility Design → HVAC Control → Equipment Cleaning → Personnel Hygiene → SOP
Compliance
Summary / Memory Trick
💡 “Five Fences Stop Contamination”
F – Facility Design
F – Filtration (HVAC)
S – Sanitation (Equipment)
C – Clothing (Personnel)
S – SOP Compliance
Frequently Asked in RGUHS: ✅
“Define cross-contamination and explain its prevention” — Repeated in 2018, 2020,
2022, 2024
Q4(a). Write a note on ISO 9000 with merits and demerits
📘 References:
Pharmaceutical Quality Assurance – Nirali Prakashan, Ch. 10, pp. 170–174
Pharmaceutical Quality Assurance – Thakur Publication, Unit V, pp. 189–193
ISO 9000:2015 Standard, International Organization for Standardization
(Geneva)
WHO TRS 986, Annex 2
Introduction
ISO 9000 is a family of international standards developed by the International
Organization for Standardization (ISO) that provides guidelines for quality
management systems (QMS).
The ISO 9000 series helps pharmaceutical industries ensure that their products and
services consistently meet customer and regulatory requirements, and that
continuous improvement is maintained.
